Characteristics | Both | Male | Female |
---|---|---|---|
1990 | Â | Â | Â |
Mortality/10,000 (95% UI) | 8.84(8.31, 9.35) | 5.76(5.40, 6.26) | 3.08(2.76, 3.44) |
DALYs/100,000 (95% UI) | 18.84(17.84, 20.07) | 12.89(12.00, 14.22) | 5.95(5.34, 6.83) |
ASMR (95% UI) | 2.54(2.35, 2.69) | 3.87(3.61, 4.18) | 1.58(1.41, 1.76) |
ASDR (95% UI) | 48.79(46.01, 51.80) | 74.09(69.27, 81.15) | 28.52(25.56, 32.53) |
2021 | Â | Â | Â |
Mortality/10,000 (95% UI) | 15.39(13.84, 16.57) | 9.39(8.66, 10.22) | 6.01(5.13, 6.63) |
DALYs/100,000 (95% UI) | 31.08(28.57, 33.54) | 20.50(19.09, 22.54) | 10.58(9.39, 11.61) |
ASMR (95% UI) | 1.86(1.67, 2.00) | 2.57(2.36, 2.79) | 1.28(1.10, 1.42) |
ASDR (95% UI) | 36.54(33.52, 39.46) | 51.78(48.04, 56.76) | 23.01(20.49, 25.27) |
1990–2021 |  |  |  |
Mortality (%) | 74.22 | 63.08 | 95.04 |
DALYs (%) | 64.94 | 59.08 | 77.64 |
AAPC of ASMR (95% CI) | -0.99(-1.06, -0.91) | -1.31(-1.39, -1.24) | -0.64(-0.77, -0.52) |
AAPC of ASDR (95% CI) | -0.90(-0.98, -0.83) | -1.14(-1.23, -1.06) | -0.68(-0.79, -0.57) |